Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to AML
Related studies linked through entity extraction aliases.
Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD
- Status
- COMPLETED
- Phase
- PHASE2
Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders
- Status
- COMPLETED
- Phase
- PHASE2
Lipid Use, Nutrition, and Colitis in Patients With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders
- Status
- COMPLETED
- Phase
- N/A
A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status
- Status
- COMPLETED
- Phase
- PHASE1
Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
Study of XL999 in Patients With Acute Myeloid Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE2
Study of Bexarotene in Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Stem Cell Transplant for Hematological Malignancy
- Status
- TERMINATED
- Phase
- NA
Stem Cell Transplantation for Hematological Malignancies
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Post Transplant Donor Lymphocyte Infusion
- Status
- TERMINATED
- Phase
- PHASE2
Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia
- Status
- COMPLETED
- Phase
- NA
Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies
- Status
- COMPLETED
- Phase
- EARLY_PHASE1